BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Wednesday reported a loss of $1.5 million in its fourth quarter.
The Beverly Hills, California-based company said it had a loss of 34 cents per share.
The biotechnology company posted revenue of $222,100 in the period. Its adjusted revenue was $222,000.
For the year, the company reported that its loss narrowed to $7.6 million, or $2.06 per share. Revenue was reported as $1 million.
In the final minutes of trading on Wednesday, the company's shares hit $1.09. A year ago, they were trading at $5.70.